Meletios Therapeutics
PrivateLast Round
Grant
Jun 29, 2023
Total Funding Raised
$8.45M
Company Overview
Meletios Therapeutics is a biotechnology company that develops broad-spectrum antiviral treatments targeting host mechanisms to combat current and emerging viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Meletios Therapeutics Comparables
Compare Meletios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atriva Therapeutics GmbH | 83% | |
| Astremiha Therapeutics | 80% | |
| Kimer Med | 79% |
Meletios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 29, 2023 | ||||
| Grant | Jun 15, 2022 | ||||
| Seed | Sep 1, 2021 |
Meletios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2022
Secured $2.66M from the European Innovation Council Fund.
- Sep 1, 2021
$4.5M raised in Seed round.
Meletios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Meletios Therapeutics's valuation, stock price, and market status.
Is Meletios Therapeutics a public or private company?
Meletios Therapeutics is a private company.
What is the current stock price of Meletios Therapeutics?
Meletios Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Meletios Therapeutics worth (valuation)?
Valuation information for Meletios Therapeutics is not publicly available.
Can I buy Meletios Therapeutics stock?
Meletios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Meletios Therapeutics's last funding round?
Meletios Therapeutics's most recent funding round was Grant on June 29, 2023.
Who are the main investors in Meletios Therapeutics?
Key investors in Meletios Therapeutics include European Innovation Council, Bpifrance.
Will Meletios Therapeutics IPO soon?
No public IPO plans have been announced for Meletios Therapeutics.
How can I track Meletios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Meletios Therapeutics's secondary market activity and sign up for updates.